XTalks

MAY 9, 2024

First, the integration of AI, big data and high-performance computing has the potential to not only expedite the drug discovery process, but also could contribute to better understanding of diseases at the molecular level. Tahi Ahmadi: Two key areas where we anticipate breakthroughs are technological advancements and new modalities.

Antibody 52

Antibody Clinical Trials Clinical Trials Medicine 52

Drug Discovery World

SEPTEMBER 7, 2022

R&D cloud platform provider Benchling recently released a new AI programme to help scientists predict 3D structures of novel proteins. The company launched a beta version of its AlphaFold programme – an AI platform developed by DeepMind that can predict the 3D structure of a protein from an amino acid sequence.

Drugs 52

Drugs Development Clinical Trials Clinical Trials 52

Delveinsight

AUGUST 18, 2021

Smartphone applications provide information related to nutritional status in recipes by segmenting them into fats, proteins, carbohydrates, and sugars. Apart from these, the entry of big data and Virtual health technologies will also provide new insights and support to Diabetes management immensely in the coming years.

Insulin 94

Insulin Marketing Development Big Data 94

Drug Discovery World

FEBRUARY 6, 2024

Sanofi has stated that it intends to become the first pharma company “powered by AI at scale”, and as part of this ambition, agreed a collaboration with BioMap to co-develop advanced AI models and protein Large Language Models that that it hopes will enable biologics design and multiparametric optimisation 2.

Marketing 69

Marketing Medicine Genome Genomics 69

Drug Discovery World

MAY 4, 2023

The drug target for Penicillin is a protein that helps bacteria to synthesise its cell wall. One of the first and most basic requirements for a protein to be characterised as a drug target is to show that inhibiting its function prevents the disease. Big data handling and machine learning made progress by leaps.

Medicine 52

Medicine Protein Drugs Bioassay 52

pharmaphorum

DECEMBER 8, 2022

These groundbreaking discoveries ushered in a new age of precision and personalized medicine, leading to innovations in novel targeted proteins, cell and gene therapies, and medical devices, which are often accompanied by bespoke diagnostic and testing criteria.

Big Data 96

Big Data Gene Therapy Medicine Marketing 96

pharmaphorum

SEPTEMBER 18, 2020

The same year, AZ also entered into its third collaboration agreement with Astex Therapeutics, this time to develop small-molecule protein kinase B (PKB) to further contribute in the fight against cancer. AstraZeneca’s first acquisition following its creation was of KuDOS Pharmaceuticals, a UK biotech company, for £120 million in 2005.

Pharma Companies 116

Pharma Companies Sales Vaccination Vaccine 116

Drug Discovery World

SEPTEMBER 5, 2022

Modulations in protein expression levels or the presence of dysfunctional proteins observed in individuals with specific mutations act as biomarkers in selecting patients for targeted therapies. . When selecting patients for therapy, we currently look at variants that directly affect protein expression or function.

Development 52

Development Drugs Protein Genome 52

Drug Discovery World

SEPTEMBER 6, 2022

The use of big data and AL to direct the best patient candidates for CGT and to provide the best understanding of efficacy and benefits.” – ? Many millions of people have recently been vaccinated against Covid 19 with a genetically modified viral vector (a recombinant adenovirus expressing a Covid 19 protein).

Gene Therapy 52

Gene Therapy Gene Manufacturing Medicine 52

XTalks

AUGUST 2, 2023

Johnson & Johnson’s Top 5 Best-Selling Drugs of 2022: 1) Stelara (ustekinumab) Stelara is an immunosuppressant biologic therapy that blocks the IL-12 and IL-23 proteins that play a role in plaque psoriasis and Crohn’s disease. The monoclonal antibody targets CD20, a protein found on the surface of B lymphocytes (B cells).

Sales 98

Sales Manufacturing FDA Approval Life Science 98